Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
EtiraRx Logo
EtiraRx Growth Score
93
CB Rank
27618
Heat Score
81
EtiraRx is a biopharmaceutical research firm that offers treatment for therapy-resistant metastatic breast cancer.
Founded
obfuscation
PrivateVenture - Series Unknown Dallas, Texas, United States1-10 www.etirarx.com
Biotechnology
Health Care
Medical
Overview

EtiraRx
Total Funding
obfuscation
Growth Score
93
Heat Score
81

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score93
-1 pts
in past quarter
Heat Score 81
13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About EtiraRx

CB Rank
27618
EtiraRx is a biopharmaceutical research firm that offers treatment for therapy-resistant metastatic breast cancer.
Founded
obfuscation
PrivateVenture - Series Unknown Dallas, Texas, United States1-10 www.etirarx.com
Biotechnology
Health Care
Medical

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name EtiraRx, Inc
Operating Status Active
Company Type For Profit
Founders  Ganesh Raj, Jung Ahn, Ratna Vadlamudi
About the Company
EtiraRx offers translation of research, from the systemic evaluation of mechanisms of therapy resistance to the development of novel therapeutics to treat cancers. The company's contact modes are by mail, phone, and physical address.
Contact Email contact@etiraRx.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

ERX-315
A compound designed to induce endoplasmic reticulum stress in cancer cells, leading to cell death, and is effective against multiple forms of endocrine therapy-resistant breast cancer.
ERX-208
A drug active against all four molecular subtypes of ovarian cancer, dependent on LIPA expression, and is being advanced towards clinical trials.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - EtiraRx Logo
Venture Round - EtiraRx
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - EtiraRx Logo
Venture Round - EtiraRx
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - EtiraRx Logo
Venture Round - EtiraRx
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - EtiraRx Logo
Venture Round - EtiraRx
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - EtiraRx Logo
Venture Round - EtiraRx
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - EtiraRx Logo
Venture Round - EtiraRx
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - EtiraRx Logo
Venture Round - EtiraRx
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - EtiraRx Logo
Venture Round - EtiraRx
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - EtiraRx Logo
Venture Round - EtiraRx
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - EtiraRx Logo
Venture Round - EtiraRx
—
obfuscation
— Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Board Members and Advisors 8 Contacts 2

Employee Profiles

Board Members and Advisors

News

News and Press

News•Oct 5, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 28, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$48.9KThis year, EtiraRx is projected to spend $48.9K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Customer Portal Logo
Customer Portal
67

Active Website Tech Count

6EtiraRx is actively using 6 technologies for its website, according to BuiltWith. These include SPF, U.S. Server Location, and  Microsoft Exchange Online.

Total IP

1EtiraRx has 1 registered trademark in the 'Scientific and technological services' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is EtiraRx's headquarters? EtiraRx is located in Dallas, Texas, United States.When was the last funding round for EtiraRx? EtiraRx closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are EtiraRx's competitors? Alternatives and possible competitors to EtiraRx may include Eli Lilly, Pfizer, and  AstraZeneca.How much funding has EtiraRx raised to date? EtiraRx has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|